Table 3.
Obstetric complications among SARS‐CoV‐2 positive and SARS‐CoV‐2 negative pregnant women
| Obstetric complications | SARS‐CoV‐2 positive pregnant women (108) | SARS‐CoV‐2 negative pregnant women (3057) | Estimated effect (95% CI) | p |
|---|---|---|---|---|
| Hemoglobin (HB < 10) | 24 (22.2%) | 504 (16.4%) | 5.8 (−1.13 to 14.60) | p = 0.1114 |
| Gestational diabetes mellitus | 16 (14.8%) | 334 (10.9%) | 3.9 (−1.70 to 11.87) | p = 0.2037 |
| Pregnancy‐induced hypertension | 12 (11.1%) | 264 (7.39%) | 3.71 (−1.02 to 11.07) | p = 0.1507 |
| Intrahepatic cholestasis | 10 (9.2%) | 212 (6.93%) | 2.27 (1.97–9.25) | p = 0.3638 |
| Antepartum hemorrhage | 6 (5.55%) | 132 (4.3%) | 1.25 (−1.83 to 7.32) | p = 0.5311 |
| Postpartum hemorrhage | 5 (4.6%) | 110 (3.59%) | 1.01 (−1.71 to 6.78) | p = 0.5811 |